ArticleCancer letters2026

Genome-wide CRISPR screen identifies PKMYT1 inhibition as a synthetic lethal vulnerability in IDH1-mutant glioma.

Fengchao Lang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.